• SENSEX 74,525.19
    -256.57 (--0.34%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • HDFC Bank
    730.30 1,020.35(%)
  • Raymond
    1,121.80 1,024.00(%)
  • Solar Industries
    19,450.15 11,641.10(%)
  • Zensar Tech.
    479.80 868.50(%)
  • Infosys
    1,097.40 1,727.85(%)
  • Tata Inv.Corpn.
    750.30 1,184.00(%)
  • ESDS Software
    1,802.15 1,716.35(%)
  • TCS
    2,322.50 3,336.70(%)
  • Reliance Industries
    1,249.00 1,250.55(%)
  • Pine Labs
    191.50 134.75(%)
  • Netweb Technol.
    4,675.00 2,820.80(%)
  • Hero Motocorp
    5,325.55 6,390.00(%)
  • Gland Pharma
    2,882.00 1,575.00(%)
  • SBI
    979.00 816.25(%)
  • Bharat Electron
    387.65 380.35(%)
  • Coforge
    1,780.00 1,008.50(%)
  • HCL Technologies
    1,290.10 1,770.00(%)
  • Afcons Infrastr.
    304.70 479.05(%)
  • IFCI
    77.80 46.20(%)
  • Molbio Diagnosti
    1,274.05 925.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Tyche Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 21199.0
  • ISIN : INE443B01012
108.95 -4 (-3.11%)
  • As on 15 Sep 2026 (EOD)

  • Today’s Low

    108.30

  • Today’s High

    113.55

  • Open

    113.55

  • Perv Close

    112.45

  • 52W Low

    99.00

  • 52W High

    148.00

Key Indicators

  • P/E(TTM)

    25.05

  • Mar.Cap (₹Cr.)

    111.67

  • Div & Yield %

    3.21

  • Book Value(₹)

    137.05

  • Debt-Equity Ratio

    -3.11

  • AGM Date

    11-Sep-2026

  • EPS

    4.35

  • P/E Ratio

    25.05

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    111.67

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.25

  • BV (₹)

    137.00

  • Sales( ₹ in Cr.)

    53.63

  • NP (in Cr.)

    6.93

  • NP Var(%)

    -44.0

  • Div%

    35.0

  • CPS (₹)

    8.70

  • EPS (₹)

    6.80

  • Traded Value (₹ in Lakhs)

    111.67

  • 52 Week High

    148.00

  • 52 Week Low

    99.00

  • Price BSE

    109.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    111.67

  • P/C Ratio

    12.50

  • P/E Ratio

    16.10

  • Price Vs.BV

    6.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 53.63 65.47 69.51 75.39 62.27 78.24
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 53.63 65.47 69.51 75.39 62.27 78.24
Other Income 9.22 7.42 5.92 4.83 5.11 4.74
Stock Adjustments -2.97 2.57 -1.21 2.14 2.57 -0.91
Total Income 59.88 75.46 74.22 82.36 69.95 82.07
EXPENDITURE :            
Raw Materials 21.18 27.40 27.97 35.74 30.23 26.08
Power and Fuel Cost 3.68 4.37 4.13 3.92 2.86 3.83
Employee Cost 8.60 7.88 7.81 6.96 6.68 6.55
Other Manufacturing Expenses 7.21 7.20 7.81 5.87 6.22 8.71
Selling and Administration Expenses 6.88 9.07 7.05 8.01 6.98 6.92
Miscellaneous Expenses 0.87 0.82 0.88 1.00 2.57 1.51
Employee Benefit Expenses 8.60 7.88 7.81 6.96 6.68 6.55
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 48.42 56.74 55.65 61.49 55.53 53.61
Operating Profit 11.46 18.71 18.57 20.86 14.43 28.47
Interest 0.00 0.00 0.00 0.00 0.00 0.01
Gross Profit 11.46 18.71 18.57 20.86 14.43 28.46
Depreciation 2.00 1.99 1.94 1.77 1.79 1.72
Profit Before Tax 9.46 16.72 16.63 19.09 12.64 26.74
Current Tax 2.57 4.39 4.46 5.03 3.39 6.73
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.04 -0.09 -0.07 -0.12 -0.09 0.02
Reported Net Profit 6.94 12.41 12.24 14.17 9.33 19.98
Extraordinary Items 0.00 0.03 0.00 -0.09 -0.51 -0.74
Adjusted Net Profit 6.94 12.38 12.24 14.26 9.84 20.72
Adjustment below Net Profit -0.09 0.11 -0.40 -0.19 -0.21 -0.17
P & L Balance brought forward 118.58 108.91 99.42 87.08 79.19 60.55
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.37 2.86 2.35 1.84 1.32 1.32
P & L Balance carried down 122.05 118.58 108.91 99.23 87.00 79.04
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 35.00 30.00 25.00 0.00 15.00 10.00
Dividend Per Share(Rs) 3.50 3.00 2.50 0.00 1.50 1.00
Earnings Per Share-Unit Curr 6.77 12.12 11.95 13.83 9.11 19.51
Earnings Per Share(Adj)-Unit Curr 6.77 12.12 11.95 13.83 9.11 19.51
Book Value 137.11 133.43 123.70 113.96 101.72 93.66
Book Value(Adj)-Unit Curr 137.11 133.43 123.70 113.96 101.72 93.66

Shareholding Pattern

  • Promoter Group

    61.97%

  • Public Share Holding

    38.03%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,085,641 39.86 4,085,641 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,265,855 22.11 2,265,855 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,351,496 61.97 6,351,496 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 758,293 7.40 758,293 54
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 107,620 1.05 107,620 122
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 157,913 1.54 157,913 163
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 521,097 5.08 521,097 13
Individuals holding nominal share capital up to Rs. 1 lakh 2,201,810 21.48 2,082,597 6,423
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 151,771 1.48 151,771 3
Sub Total 3,898,504 38.03 3,779,291 6,778
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,250,000 100.00 10,130,787 6,786

Company Background

Tyche Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Tyche Industries Ltd
  • BSE Code : 21199.0
  • ISIN : INE443B01012

  • Incorporation Year

    1998

  • Registered Office

    H No C-21/A Road No 9
    Film Nagar Jubilee Hills, Hyderabad,
    Telangana-500096

  • Telephone

    91-40-23541688/23540933

  • FAX

    91-40-23540933

  • Chairman

    G Ganesh Kumar

  • Managing Director

  • Company Secretary

    Pradosh Ranjan Jena.

  • Auditor

    P S N Ravishanker & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Tyche Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Tyche Industries 108.95 62.86 53.63 25.05 6.83
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77